Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant - PubMed
TEQOOZ® 4-Switch Smart Wi-Fi + Bluetooth Touch Switch (Black) (6 Amp Each) | Smart Life App Control I Compatible with Alexa, Google Home, Siri | Pure Glass : Amazon.in: Home Improvement
Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant - PMC
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study | Journal of Clinical Oncology